Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136000 | PMC |
| http://dx.doi.org/10.1093/ndt/gfab174 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Outcomes of Covid-19 Vaccine-Associated Glomerular Diseases (CVAGD) - A Case Series from India.
Indian J Nephrol
July 2024
Department of Nephrology, Madras Medical College, Chennai, Tamil Nadu, India.
Background: Several cases of glomerular diseases following Covid-19 vaccination, especially mRNA vaccines, have been reported. However, there is little data on glomerular diseases associated with the two vaccines widely available in India (Covaxin and Covishield) and their long-term outcomes.
Materials And Methods: This was a prospective observational study conducted between May 2021 and May 2023.
Systemic Vasculitis Post-COVID-19: A Case Report.
Cureus
October 2024
Internal Medicine, Jalalabad Ragib-Rabeya Medical College, Sylhet, BGD.
Article Synopsis
- Vasculitis is a potential complication of COVID-19, where the virus can trigger or worsen autoimmune diseases like systemic vasculitis.
- The case of an elderly patient with multiple health issues highlighted the connection, as doctors diagnosed vasculitis due to renal function decline and positive antinuclear antibodies.
- A kidney biopsy confirmed focal necrotizing and crescentic glomerulonephritis, emphasizing the need for awareness of COVID-19 related complications and a broad differential diagnosis in recovering patients.
[ANCA-Associated Glomerulonephritis Following SARS-CoV2 Infection: A Case Report].
G Ital Nefrol
October 2024
UOC Pronto Soccorso e Medicina d'Urgenza, P.O. San Filippo Neri, ASL Roma 1, Roma.
Article Synopsis
- Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) primarily targets small- and medium-sized arteries, leading to conditions like rapidly progressive glomerulonephritis, particularly affecting the kidneys.
- Infections are known triggers for this autoimmune disorder, and recent studies suggest a link between SARS-CoV-2 infection and acute kidney injury (AKI).
- The text presents a specific case of a 61-year-old man who developed new-onset diffuse proliferative ANCA-associated glomerulonephritis following COVID-19.
A case of de novo glomerulonephritis following COVID-19 in a patient with preexistent IgA vasculitis.
CEN Case Rep
October 2024
Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan.
Article Synopsis
- * A case study discusses a young Japanese woman with preexisting IgAV who developed glomerulonephritis after contracting COVID-19, experiencing symptoms like hematuria and proteinuria following her illness.
- * After a renal biopsy confirmed her condition, she was treated with corticosteroids and showed significant improvement, indicating that COVID-19 may provoke kidney issues in IgAV patients without prior renal symptoms.
The incidence of vasculitides in Israel from 2007 to 2021 and during the COVID-19 pandemic.
Ther Adv Musculoskelet Dis
October 2024
Rheumatology Disease Unit, Soroka University Medical Center, Rager Bvd., Beer Sheva 84101, Israel.
Article Synopsis
- A study assessed the trends in various vasculitis conditions in Israel from 2007 to 2021, particularly during the COVID-19 pandemic.
- The incidence rates of giant cell arteritis, IgA vasculitis, and Behcet's disease significantly decreased over the years, while Takayasu, ANCA-associated vasculitis, and cryoglobulinemia showed no changes.
- The COVID-19 pandemic had no impact on the incidence rates of any of the examined vasculitides, suggesting that future research should explore environmental factors influencing these trends.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!